Submit Your Tips
Everyone learns from experience. Share your tips for coping with diagnosis, treatment and survivorship.
Upcoming EventsEvent List || Calendar Display
In this section, learn how to participate in Living Beyond Breast Cancer's educational conferences, webinars, Twitter chats and community meetings encompassing a wide variety of topics, as well as our special fundraising events and events for healthcare professionals.
View upcoming events and events by type; access a list of recurring LBBC events and an event archive; and access featured event listings and a library of transcripts and podcasts from past events.
View events by type:
July 2008No Events Scheduled, Showing Next Upcoming Events
Learn how a diagnosis of advanced (metastatic) breast cancer can affect your quality of life both physically and psychologically.
In this program, Dr. Ganz explains how chemotherapy and hormonal therapy can impact the severity of common menopausal symptoms.
In this program, Dr. Chlebowski explains how results of the latest clinical trials on diet and exercise may impact your risk of developing breast cancer or a recurrence.
Over 660 supporters raised more than $700,000 for Living Beyond Breast Cancer’s education and support programs at our annual gala, The Butterfly Ball, on September 27, 2008, at the Lowes Philadelphia Hotel.
Find out about the latest medical treatments to manage advanced (metastatic) breast cancer.
|Understand the differences between ductal carcinoma in situ (DCIS), lobular carcinoma in situ (LCIS) and invasive breast cancer while learning about treatment options.|
Learn how medical and lifestyle interventions can help you manage symptoms and side effects.
In this publication, explore ways to talk about your needs, whether you are in treatment, have completed treatment or are living with metastatic breast cancer.
Nutrition and breast cancer are frequently discussed in the popular media.
Almost 15 years ago, researchers discovered that women who carry mutations of BRCA1 or BRCA2 are at higher risk of developing breast and/or ovarian cancer compared to women who do not have one of these genetic mutations.